Harrisvaccines, today announced it has been granted United States Department of Agriculture (USDA) conditional licensure of the company’s Porcine Epidemic Diarrhea Virus (PEDV) Vaccine, RNA. This is the first USDA conditional license granted for a PEDV vaccine since the initial outbreak of the disease, and it will allow Harrisvaccines to sell their vaccine directly to the veterinarians and swine producers battling PEDV.
“Using our unique rapid-response production methods, we were able to create a vaccine in a matter of weeks after the outbreak,” says Joel Harris, Head of Sales and Marketing for Harrisvaccines, based in Ames, IA. “Since late 2013, we have sold nearly 2 million doses of this vaccine through veterinary prescription and we are now thrilled to say it has been granted a USDA conditional license.”
The vaccine is given to sows one week to 10 days prior to farrowing in order to boost antibody levels and help transfer those antibodies to piglets, via colostrum, upon farrowing.
“The impact of this disease has been devastating,” said Hank Harris, DVM, Founder and CEO of Harrisvaccines. “At Harrisvaccines, we recognized the great threat that PEDV posed to the industry immediately and that is why we are able to introduce the first USDA conditionally licensed PEDV vaccine on the market.”
The USDA generally grants conditional licenses in order to meet an emergency or unmet need. A conditionally licensed product must show a reasonable expectation of efficacy and all safety and purity requirements must be met.